TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure
Recruiting now · Not applicable
Conditions studied: Heart Failure
In brief
The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: * Is a tailored text messaging intervention feasible and acceptable among older adult patients with heart failure? * Does tailored text messaging improve self-care in adult patients with heart failure? Participants will be randomly assigned to one of two groups for 12 weeks: 1) intervention (text messaging); or 2) control group. Both groups will receive usual care, which includes regular follow-up visits at the heart failure clinic (standard care), plus a "Discharge Packet for Patients Diagnosed with Heart Failure", developed by the American Heart Association. Both groups will be asked via text messages and/or telephone calls to complete questionnaires at baseline/start, 4 weeks and 12 weeks, about self-care, quality of life, health beliefs, medications, diet, etc. Participants assigned to the intervention group will also receive approximately 5 text messages/week targeting medication adherence, heart-healthy diet, and self-monitoring for 12 weeks.
Key facts
- Study ID
- NCT06473532
- Run by
- University of Illinois at Chicago
- People needed
- 30
- Starts
- 2024-09-26
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2025-09-11
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥50 years of Age
- HF Stage C, NYHA Class I-IV and on a loop diuretic
- Own a Mobile phone with Text message plan
- Ability to speak and read English
- Suboptimal HF self-care. (SCHFI Score of 3 or less in at least 2 items of any subscale: Self-care maintenance, Symptom Perception, or Self-management)
You may not qualify if…
- SAVR/TAVR or Ventricular Assist Device, or Cardiac Resynchronization Therapy (CRT) - implantation, and/or heart transplantation (HTx) scheduled within the next 3 months
- Coronary revascularization, and/or CRT-implantation within the last 30 days (EMR Review)
- Psychosis
- Hospice or End-of-life care
- Advanced Renal disease (i.e., estimated Glomerular Filtration Rate <25 or Hemodialysis)
- Cognitive impairment (i.e., Dementia, Alzheimer's)
- Unable to self-manage (take medication, bathe, use the toilet, etc.)
- Currently living in a nursing home
Where it is running
- University of Illinois, Chicago — Chicago, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.